The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The nature of the noradrenergic dysregulation in clinical anxiety disorders remains unclear. In panic disorder, the predominant view has been that central noradrenergic neuronal networks and/or the sympathetic nervous system was normal in patients at rest, but hyper-reactive to specific stimuli, for example carbon dioxide. These ideas have been extended to other anxiety disorders, which share with panic disorder characteristic subjective anxiety and physiological symptoms of excess sympathetic activity. For example, Generalized Anxiety Disorder is characterized by chronic free-floating anxiety, muscle tension, palpitation and insomnia. It has been proposed that there is chronic central hypersecretion of noradrenaline in Generalized Anxiety Disorder, with consequent hyporesponsiveness of central post-synaptic receptors. With regards to other disorders, it has been suggested that there is noradrenergic involvement or derangement, but a more specific hypothesis has not been enunciated. This paper reviews the evidence for noradrenergic dysfunction in anxiety disorders, derived from indirect measures of noradrenergic function in clinical populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
False Suffocation Alarms, Spontaneous Panics, and Related Conditions: An Integrative Hypothesis
Klein, D. F. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820160076009 · Cited by 1,130 · cited 1×
“It was hypothesized that panic disorder patients had a greater sensitivity to hypercapnia and that a ‘suffocation false alarm’ drove the panic response (Klein, 1993).”
BackgroundCharney, D. S. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790190025003 · Cited by 599 · cited 6×
“While the rise in systolic blood pressure accompanying yohimbine in panic disorder patients consistently exceeded that of healthy controls, increase in pulse occurred only in one study in those patients in whom panic attacks were provoked (Charney et al., 1984; Charney et al., 1987) probably because any increase in ra…”
BackgroundInfluentialCSF Norepinephrine Concentrations in Posttraumatic Stress Disorder
Geracioti, T. D., Baker, D. G., Ekhator, N. N., West, S. A., Hill, K. K., Bruce, A. B., Schmidt, D., Rounds-Kugler, B., Yehuda, R., Keck, P. E., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1227 · Cited by 462
Turton, M. B., & Deegan, T. (1974) · Clinica Chimica Acta · doi:10.1016/0009-8981(74)90014-x · Cited by 322 · cited 2×
“Noradrenaline and its metabolites also vary according to the effects of time of day (Turton and Deegan, 1974), menstrual cycle (Hirshoren et al.”
BackgroundWilkinson, D. J. C., Thompson, J. M., Lambert, G. W., Jennings, G. L., Schwarz, R. G., Jefferys, D., Turner, A. G., & Esler, M. D. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.6.511 · Cited by 214
Leckman, J. F., Goodman, W. K., Anderson, G. M., Riddle, M. A., Chappell, P. B., McSwiggan-Hardin, M. T., McDougle, C. J., Scahill, L. D., Ort, S. I., Pauls, D. L., et al. (1995) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380241 · Cited by 169 · cited 2×
“A single such study of social phobia showed no difference in plasma noradrenaline relative to healthy controls at baseline or in response to an orthostatic challenge (Leckman et al., 1995; Stein et al., 1992).”
BackgroundGorman, J. M., Kent, J., Martinez, J., Browne, S., Coplan, J., & Papp, L. A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.2.125 · Cited by 123
Murphy, S. E., Yiend, J., Lester, K. J., Cowen, P. J., & Harmer, C. J. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009164 · Cited by 90 · cited 1×
“However, citalopram, but not reboxetine, was found to reduce vigilance towards fearful faces in healthy volunteers (Murphy et al., 2008).”
BackgroundSmajkic, A., Weine, S., Djuric‐Bijedic, Z., Boskailo, E., Lewis, J., & Pavkovic, I. (2001) · Journal of Traumatic Stress · doi:10.1023/a:1011177420069 · Cited by 89
α2Adrenergic and Opiate Receptor Blockade: Synergistic Effects on Anxiety in Healthy Subjects
Charney, D. S. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800110023004 · Cited by 61 · cited 1×
“In healthy individuals, clonidine lowers blood pressure and plasma MHPG via sympathetic nervous system inhibition, as well as reducing anxiety and arousal (Charney and Heninger, 1986; Nutt and Molyneux, 1986).”
Background
Cited by
Handbook of Religion and Health
Koenig, H. G., VanderWeele, T., & Peteet, J. R. (2024) · doi:10.1093/oso/9780190088859.001.0001 · Cited by 1,139
The Integrative Role of the Sigh in Psychology, Physiology, Pathology, and Neurobiology
Ramirez, J.-M. (2014) · Progress in Brain Research · doi:10.1016/b978-0-444-63274-6.00006-0 · Cited by 120
“Autonomic dysregulation is an aspect of some of these disorders, but sighs have not been specifically characterized in these disorders, (Beauchaine et al., 2007; Heilman et al., 2011; Kalk et al., 2011; Musser et al., 2013).”
BackgroundPsychiatric symptoms of noradrenergic dysfunction: A pathophysiological view
Yamamoto, K., Shinba, T., & Yoshii, M. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12126 · Cited by 88
“As Kalk et al.103 have noted, the NAergic pathophysiology of anxiety disorders may vary depending on the disorder’s clinical sub-classification.”
BackgroundCortisol and alpha-amylase assessment in psychotherapeutic intervention studies: A systematic review
Laufer, S., Engel, S., Knaevelsrud, C., & Schumacher, S. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.023 · Cited by 34
Personalized Clinical Approaches to Anxiety Disorders
Perna, G., Alciati, A., Sangiorgio, E., Caldirola, D., & Nemeroff, C. B. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-32-9705-0_25 · Cited by 15
Metadata
- Authors
- Kalk, N., Nutt, D., & Lingford-Hughes, A.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2010-06-08
- Volume
- 25
- Issue
- 1
- Pages
- 3-16
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2014271591
- Cited by
- 123
- References
- 16
- FWCI
- 8.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies. https://app.cochat.ai/papers/10.1177/0269881110367448
- The paper
- Kalk, N., Nutt, D., & Lingford-Hughes, A. (2011). The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies. Journal of Psychopharmacology. https://doi.org/10.1177/0269881110367448
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.